6 completed, 3 unknown, 3 withdrawn, 2 active not recruiting. 20 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 20 | Completed 6, Unknown 3, Withdrawn 3, Active not recruiting 2, Not yet recruiting 2, Recruiting 2, Terminated 2 |
Follow Epileptic Syndromes: new trials by email Literature Review of Epileptic Syndromes trials Research Report on Epileptic Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex Epidiolex 100 mg/mL Oral Solution - Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS) | Phase 4 | Not yet recruiting | Elizabeth Donner | 25 | 2027-01-01 | 2026-09-11 |
| A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS Cannabidiol Oral Solution - Lennox-Gastaut Syndrome | Phase 4 | Not yet recruiting | Jazz Pharmaceuticals | 40 | 2026-11-18 | 2026-11-17 |
| The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project Fenfluramine treatment (Fintepla), Hypercapnia Challenge using the device (RespirAct) - Dravet Syndrome | Phase 4 | Recruiting | The University of Texas Health Science Center, Houston | 25 | 2026-04-27 | 2026-07-15 |
| Clinical Trial on 7-day Followed by Maintenance Therapy for 10 Weeks vs. 14-day and no Maintenance Course of Prednisolone for the Treatment of Infantile Epileptic Spasms Syndrome (IESS) Short-Duration Oral Prednisolone with Extended Tapering, Standard Oral Prednisolone Regimen with Tapering - Spasms, Infantile, Prednisolone | Phase 4 | Active not recruiting | University of Colombo | 182 | 2025-01-01 | 2025-02-24 |
| Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age fenfluramine - Dravet Syndrome (DS), Children Under 2 Years | Phase 4 | Recruiting | University of Colorado, Denver | 5 | 2024-10-22 | 2026-05-15 |
| Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution Cannabidiol - Lennox Gastaut Syndrome, Dravet Syndrome | Phase 4 | Active not recruiting | Jazz Pharmaceuticals | 154 | 2021-07-07 | 2026-08-26 |
| Fenfluramine and Cognition Fenfluramine, Placebo - Cognitive Function | Phase 4 | Completed | University of Oxford | 56 | 2021-04-12 | 2022-11-15 |
| Investigation of Cognitive Outcomes With Cannabidiol Oral Solution GWP42003-P - Lennox-Gastaut Syndrome | Phase 4 | Withdrawn | Jazz Pharmaceuticals | 2020-10-01 | 2022-09-01 | |
| Hippocampal and Thalamic DBS for Bilateral Temporal Lobe Epilepsy deep brain stimulation - Epilepsy, Temporal Lobe | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 80 | 2019-11-01 | 2019-11-15 |
| Changing Agendas on Sleep, Treatment and Learning in Epilepsy Carbamazepine, Levetiracetam, Parent based sleep (PBS) intervention - Rolandic Epilepsy | Phase 4 | Terminated | King's College London | 5 | 2019-08-02 | 2020-11-02 |
| Electroclinical Effect of Steroid in Patients With Benign Childhood Epilepsy With Centrotemporal Spikes conventional antiepileptic drugs, oral steroid - Benign Childhood Epilepsy With Centrotemporal Spikes | Phase 4 | Unknown | Assiut University | 100 | 2018-06-20 | 2020-08-13 |
| Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines SPG Block with 5% Lidocaine gel, Amitriptyline - Transformed Migraine, Chronic Daily Headache | Phase 4 | Terminated | Rutgers, The State University of New Jersey | 10 | 2014-05-01 | 2026-06-23 |
| Evaluation of Neuroinflammation in Children With Infantile Spasms ACTH - Infantile Spasms | Phase 4 | Completed | Wayne State University | 8 | 2013-03-01 | 2017-11-07 |
| An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms Vigabatrin - Infantile Spasms | Phase 4 | Withdrawn | Lundbeck LLC | 2012-06-01 | 2012-09-13 | |
| Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects melatonin, placebo - Lennox-Gastaut Syndrome | Phase 4 | Withdrawn | Institution de Lavigny | 2011-08-01 | 2022-07-14 | |
| Transcranial Direct Current Stimulation, Treatment of Childhood Drug-Resistant Lennox-Gastaut Syndrome, A Pilot Study tDCS - Lennox-Gastaut Syndrome | Phase 4 | Completed | Khon Kaen University | 22 | 2010-08-01 | 2016-06-29 |
| Donepezil Double Blind Trial for ECT Memory Disfunction Donepezil - Schizophrenia, Schizoaffective Disorder | Phase 4 | Unknown | BeerYaakov Mental Health Center | 40 | 2007-05-01 | 2009-01-27 |
| Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy escitalopram, placebo - Major Depression, Temporal Lobe Epilepsy | Phase 4 | Completed | Conrad, Erich J., M.D. | 8 | 2006-11-01 | 2011-07-18 |
| Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine Levels ECT treatment - Depressive Disorder, Major | Phase 4 | Completed | University of Erlangen-Nürnberg Medical School | 10 | 2006-08-01 | 2020-12-14 |
| Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy topamax - Epilepsy, Rolandic | Phase 4 | Completed | Janssen Korea, Ltd., Korea | 114 | 2002-12-01 | 2011-02-01 |
Lennox Gastaut Syndrome (6) · Epilepsies, Myoclonic (5) · Epilepsy, Rolandic (5) · Epilepsy, Temporal Lobe (3) · Spasms, Infantile (3) · Depressive Disorder, Major (2) · Epilepsy (2) · Seizures (2) · Depression (1) · Headache Disorders (1) · Liver Cirrhosis (1) · Migraine Disorders (1) · Neuroinflammatory Diseases (1) · Psychotic Disorders (1) · Recurrence (1)
Brain Diseases (20) · Central Nervous System Diseases (20) · Nervous System Diseases (20) · Epilepsy (18) · Epilepsies, Partial (8) · Epilepsy, Generalized (8) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6) · Genetic Diseases, Inborn (6) · Pathological Conditions, Signs and Symptoms (6) · Mental Disorders (4) · Pathologic Processes (4) · Depressive Disorder (2) · Mood Disorders (2) · Neurologic Manifestations (2)
Cannabidiol (4) · Fenfluramine (3) · Carbamazepine (2) · Levetiracetam (2) · Adrenocorticotropic Hormone (1) · Amitriptyline (1) · Deep Brain Stimulation (1) · Donepezil (1) · Escitalopram (1) · Melatonin (1) · Methods (1) · Oxcarbazepine (1) · Prednisolone (1) · Solutions (1) · Steroids (1)
Jazz Pharmaceuticals (3) · Assiut University (1) · BeerYaakov Mental Health Center (1) · Conrad, Erich J., M.D. (1) · Elizabeth Donner (1) · Institution de Lavigny (1) · Janssen Korea, Ltd., Korea (1) · Khon Kaen University (1) · King's College London (1) · Lundbeck LLC (1) · Rutgers, The State University of New Jersey (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · The University of Texas Health Science Center, Houston (1) · University of Colombo (1) · University of Colorado, Denver (1)
United States (7) · United Kingdom (2) · Canada (1) · China (1) · Egypt (1) · Germany (1) · Israel (1) · Sri Lanka (1) · Switzerland (1)
Carukshi Arambepola, MSc, MD (1) · Catherine J Harmer, DPhil (1) · Elizabeth Donner, MD (1) · Erich J Conrad, M.D (1) · Gamal A Abdelal, MD (1) · Giovanni B. Foletti, MD, MER (1) · Jithangi Wanigasinghe, MD, MPhil (1) · Kelly Knupp, MD (1) · Nimesha Gamhewage, MD, DCH (1) · Samden Lhatoo, MD, FRCP (1) · Shalini Sri Ranganathan, MD, PhD (1) · Shuang Wang, MD (1) · Stefan Bleich, M.D. (1)
PMID 20331461, PMID 25663221, PMID 27199889, PMID 39122687
2018 (1)